伊洛前列素治疗骨灌注不良的疗效。
Efficiency of iloprost treatment for osseous malperfusion.
机构信息
Department of Orthopaedic Surgery, University Hospital of Duesseldorf, Duesseldorf, Germany.
出版信息
Int Orthop. 2011 May;35(5):761-5. doi: 10.1007/s00264-010-0998-4. Epub 2010 Mar 21.
Abstract
Insufficient osseous blood supply results in bone marrow oedema (BMO) and/or avascular necrosis (AVN). One treatment option to support osseous perfusion is the application of stable prostacycline analog iloprost. In this clinical study, 95 patients were treated with iloprost for BMO/AVN. One hundred eighty-six bones were affected by BMO/AVN before treatment. Average follow-up was 33.0 ± 17.6 months. Pain levels could be reduced (e.g. visual analogue scale, 5.0 ± 2.2 points reduced to 1.7 ± 2.2 points) and functional scores improved (Harris hip score, 52 ± 21 points to 79 ± 17 points) in the course of treatment. According to current data, healing of advanced stages of osteonecrosis is not possible. However, the results of this case series confirm previous findings that in early stages of insufficient osseous blood flow iloprost can contribute to the relief of pain and improve joint function.
摘要
骨血供应不足会导致骨髓水肿（BMO）和/或缺血性坏死（AVN）。一种支持骨质灌注的治疗选择是应用稳定的前列环素类似物伊洛前列素。在这项临床研究中，95 名 BMO/AVN 患者接受了伊洛前列素治疗。治疗前，186 块骨头受到 BMO/AVN 的影响。平均随访时间为 33.0 ± 17.6 个月。在治疗过程中，疼痛程度可降低（例如视觉模拟评分，从 5.0 ± 2.2 分降至 1.7 ± 2.2 分），功能评分可改善（Harris 髋关节评分，从 52 ± 21 分提高至 79 ± 17 分）。根据目前的数据，晚期骨坏死的愈合是不可能的。然而，本病例系列的结果证实了先前的发现，即在骨质血流不足的早期阶段，伊洛前列素可以有助于缓解疼痛和改善关节功能。
相似文献
1
Efficiency of iloprost treatment for osseous malperfusion.伊洛前列素治疗骨灌注不良的疗效。
Int Orthop. 2011 May;35(5):761-5. doi: 10.1007/s00264-010-0998-4. Epub 2010 Mar 21.
2
Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.前列腺素I2在骨髓水肿中的应用原理——从理论到实践
Arthritis Res Ther. 2008;10(5):R120. doi: 10.1186/ar2526. Epub 2008 Oct 3.
3
The role of Iloprost on bone edema and osteonecrosis: Safety and clinical results.伊洛前列素对骨水肿和骨坏死的作用：安全性及临床结果。
Expert Opin Drug Saf. 2018 Mar;17(3):225-233. doi: 10.1080/14740338.2018.1424828. Epub 2018 Jan 23.
4
Long-term effects of intravenous iloprost therapy in patients with bone marrow oedema of the hip.静脉注射伊洛前列素治疗髋部骨髓水肿患者的长期疗效
Acta Orthop Belg. 2018 Jun;84(2):172-178.
5
Effects of intravenous iloprost therapy in patients with bone marrow oedema of the foot and ankle.静脉注射伊洛前列素治疗足踝部骨髓水肿患者的疗效
Eur J Orthop Surg Traumatol. 2014 Dec;24(8):1609-16. doi: 10.1007/s00590-013-1320-0. Epub 2013 Sep 19.
6
Efficiency of iloprost treatment for chemotherapy-associated osteonecrosis after childhood cancer.伊洛前列素治疗儿童癌症后化疗相关骨坏死的疗效
Anticancer Res. 2009 Aug;29(8):3433-40.
7
The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost.静脉注射伊洛前列素治疗股骨近端坏死相关性及特发性骨髓水肿
J Bone Joint Surg Br. 2005 Apr;87(4):560-4. doi: 10.1302/0301-620X.87B4.15658.
8
Treatment of Bone Marrow Edema of the Foot and Ankle With the Prostacyclin Analog Iloprost.用前列环素类似物伊洛前列素治疗足踝部骨髓水肿
Foot Ankle Int. 2018 Oct;39(10):1183-1191. doi: 10.1177/1071100718778557. Epub 2018 Jun 4.
9
Long-term Clinical Results after Iloprost Treatment for Bone Marrow Edema and Avascular Necrosis.伊洛前列素治疗骨髓水肿和缺血性坏死的长期临床结果。
Orthop Rev (Pavia). 2016 Mar 31;8(1):6150. doi: 10.4081/or.2016.6150. eCollection 2016 Mar 21.
10
Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients.口服伊洛前列素或曲马多治疗膝关节疼痛性骨髓水肿的短期疗效：一项针对41例患者的探索性II期研究结果
Rheumatology (Oxford). 2007 Sep;46(9):1460-5. doi: 10.1093/rheumatology/kem172. Epub 2007 Jul 17.
引用本文的文献
1
Hip joint-preserving strategies for treating osteonecrosis of the femoral head: From nonoperative to operative procedures.治疗股骨头坏死的髋关节保留策略：从非手术到手术方法
J Orthop Translat. 2025 Mar 19;51:256-277. doi: 10.1016/j.jot.2025.02.001. eCollection 2025 Mar.
2
[Pharmacological therapy for subchondral pathologies of the knee joint].[膝关节软骨下病变的药物治疗]
Orthopadie (Heidelb). 2025 May;54(5):354-360. doi: 10.1007/s00132-025-04625-8. Epub 2025 Mar 19.
3
Techniques of core decompression in the treatment of idiopathic avascular necrosis of the femoral head.治疗股骨头特发性缺血性坏死的髓芯减压技术。
Arch Orthop Trauma Surg. 2024 Dec 21;145(1):82. doi: 10.1007/s00402-024-05732-5.
4
A Current Review in the Orthopedic Management of Osteonecrosis of the knee Secondary to Treatment of Pediatric Hematologic Malignancy.小儿血液系统恶性肿瘤治疗后继发性膝关节骨坏死的骨科治疗现状综述
Orthop Rev (Pavia). 2024 Mar 24;16:115354. doi: 10.52965/001c.115354. eCollection 2024.
5
Comparison of two joint-preserving treatments for osteonecrosis of the femoral head: core decompression and core decompression with additional cancellous bone grafting.两种保髋治疗股骨头坏死的疗效比较：空芯减压术和空芯减压术联合松质骨植骨术。
J Int Med Res. 2023 Aug;51(8):3000605231190453. doi: 10.1177/03000605231190453.
6
The Use of Iloprost in the Treatment of Bone Marrow Edema Syndrome of the Proximal Femur: A Review and Meta-Analysis.伊洛前列素在治疗股骨近端骨髓水肿综合征中的应用：综述与荟萃分析
J Pers Med. 2022 Oct 23;12(11):1757. doi: 10.3390/jpm12111757.
7
The additive effect of iloprost on the biological properties of Mineral trioxide aggregate on mesenchymal stem cells.伊洛前列素对三氧化矿物凝聚体在间充质干细胞上生物学特性的叠加效应。
J Dent Sci. 2022 Jan;17(1):225-232. doi: 10.1016/j.jds.2021.03.018. Epub 2021 May 11.
8
Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment.股骨头坏死：ARCO 对发病机制、分期和治疗的最新综述。
J Korean Med Sci. 2021 Jun 21;36(24):e177. doi: 10.3346/jkms.2021.36.e177.
9
Bone marrow oedema syndrome of the foot and ankle in a paediatric population: a retrospective case series with serial MRI evaluation.儿童足踝部骨髓水肿综合征：一项采用系列MRI评估的回顾性病例系列研究
J Child Orthop. 2020 Oct 1;14(5):440-450. doi: 10.1302/1863-2548.14.190189.
10
Effectiveness of Iloprost in the Treatment of Bone Marrow Edema.伊洛前列素治疗骨髓水肿的有效性
Cureus. 2020 Sep 20;12(9):e10547. doi: 10.7759/cureus.10547.
本文引用的文献
1
Clinical and radiological outcome of the treatment of osteonecrosis of the femoral head using the osteonecrosis intervention implant.采用股骨头坏死介入植入物治疗股骨头坏死的临床和影像学结果。
Int Orthop. 2011 Apr;35(4):489-95. doi: 10.1007/s00264-009-0940-9. Epub 2010 Jan 30.
2
Impact of surgical approach on postoperative heterotopic ossification and avascular necrosis in femoral head fractures: a systematic review.手术入路对股骨颈骨折术后异位骨化和股骨头坏死的影响：系统评价。
Int Orthop. 2010 Mar;34(3):319-22. doi: 10.1007/s00264-009-0849-3. Epub 2009 Aug 13.
3
Efficiency of iloprost treatment for chemotherapy-associated osteonecrosis after childhood cancer.伊洛前列素治疗儿童癌症后化疗相关骨坏死的疗效
Anticancer Res. 2009 Aug;29(8):3433-40.
4
Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.前列腺素I2在骨髓水肿中的应用原理——从理论到实践
Arthritis Res Ther. 2008;10(5):R120. doi: 10.1186/ar2526. Epub 2008 Oct 3.
5
Avascular necrosis of the femoral head: inter- and intraobserver variations of Ficat and ARCO classifications.股骨头缺血性坏死：Ficat和ARCO分类的观察者间及观察者内差异
Int Orthop. 2008 Jun;32(3):283-7. doi: 10.1007/s00264-007-0320-2. Epub 2007 Mar 30.
6
Intravenous iloprost: a new therapeutic option for patients with post-transplant distal limb syndrome (PTDLS).静脉注射伊洛前列素：移植后远端肢体综合征（PTDLS）患者的一种新治疗选择。
Am J Transplant. 2007 Mar;7(3):667-71. doi: 10.1111/j.1600-6143.2007.01662.x. Epub 2007 Jan 11.
7
Does alendronate prevent collapse in osteonecrosis of the femoral head?阿仑膦酸盐能否预防股骨头坏死的塌陷？
Clin Orthop Relat Res. 2006 Feb;443:273-9. doi: 10.1097/01.blo.0000194078.32776.31.
8
Iloprost inhalation solution for the treatment of pulmonary arterial hypertension.用于治疗肺动脉高压的伊洛前列素吸入溶液。
Expert Opin Pharmacother. 2005 Sep;6(11):1921-30. doi: 10.1517/14656566.6.11.1921.
9
Enoxaparin prevents progression of stages I and II osteonecrosis of the hip.依诺肝素可预防髋关节I期和II期骨坏死的进展。
Clin Orthop Relat Res. 2005 Jun(435):164-70. doi: 10.1097/01.blo.0000157539.67567.03.
10
MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue iloprost.对104例不同关节部位出现疼痛性骨髓水肿且接受前列环素类似物伊洛前列素治疗的患者进行MRI对照分析。
Wien Klin Wochenschr. 2005 Apr;117(7-8):278-86. doi: 10.1007/s00508-005-0326-y.
Zotero 插件